Movement disorders at the National Institute of Neurology and Neurosurgery (INNN, Mexico City): most common diagnoses during 2022.
Objective: To provide data about the movement disorders (MD) outpatient consultation (OC) service from the INNN, Mexico City during 2022. Background: The INNN, inaugurated in…Generalized dystonia and spasticity: The fault in the mitochondria
Objective: To analyze the pattern of movement disorder in a child with mitochondrial respiratory chain disorder Background: Secondary movement disorders are often a clue to…Clinical toolkits to improve conversations about Parkinson’s dementia
Objective: To co-produce, with people living with Parkinson’s and professionals, a pair of toolkits to improve conversations about Parkinson’s dementia in the clinic: one for…Association between dysphagia and body mass index and his impact on the severity of anxiety in patients with Parkinson Disease
Objective: To describe the relation between dysphagia and body mass index and the increase in anxiety and depression in patients with parkinson’s disease. Background: Parkinson’s…Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease
Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…Natural history and disease progression biomarkers of multiple system atrophy: the ASPIRE-MSA study
Objective: To evaluate multiple system atrophy (MSA) disease progression on a panel of candidate MSA biomarkers pre-selected for their putative involvement in the pathophysiology of…Functional Neuroimaging and Follow up trends in Drug induced movement disorders.
Objective: To analyse the role of presynaptic dopaminergic imaging (TRODAT/ F Dopa PET) scans to predict long-term outcomes in patients of new onset parkinsonian symptoms…Genetic outcomes of South Asian Parkinsonism cohort: from a tertiary care hospital
Objective: To identify the genetic heterogeneity in 16 south Asian patient with Parkinson’s disease. Background: Parkinson’s disease(PD) is the second most progressive neurodegenerative disorder with…Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings.
Objective: Assess the feasibility of detecting brain iron deposition using quantitative susceptibility mapping (QSM) among patients with Parkinson’s disease (PD) in a community-based clinic setting.…An atypical presentation of Multiple System Atrophy (MSA)
Objective: To discuss the etiological differential diagnosis of the clinical phenotype characterized by myoclonus and parkinsonism. Background: The presence of myoclonus is increasingly recognized as…
- « Previous Page
- 1
- …
- 537
- 538
- 539
- 540
- 541
- …
- 1734
- Next Page »